A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.
Chemotherapy-induced acral erythema (AE) is primarily induced by hydroxyurea, methotrexate, and cytarabine, although there are rare reports of AE induced by combination chemotherapy containing bleomycin. It is thought that the accumulation of chemotherapeutic drugs in eccrine glands may cause eccrine squamous syringometaplasia (ESS), which is characterized by metaplasia and focal necrosis of the epithelium of the eccrine duct. ESS is occasionally detected in conjunction with AE, but such occurrences are relatively uncommon. This is the first report of AE with ESS induced by the administration of bleomycin alone. We also provide a summary of past cases of AE with ESS in the literature.
Tsuboi
Hiromi
H
Department of Dermatology, Kitasato University School of Medicine, Kanagawa, Japan.
Yonemoto
Kohzoh
K
Katsuoka
Kensei
K
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects*; D004439:Eccrine Glands / Q000473:pathology*; D004890:Erythema / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008679:Metaplasia / Q000139:chemically induced; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced
D000964:Antimetabolites, Antineoplastic; D001761:Bleomycin